You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cCAR

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory, Systemic Lupus Erythematosus (SLE) Trial in Zhongshan (BCMA-CD19 cCAR T cells)

Recruiting
  • Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)
  • BCMA-CD19 cCAR T cells
  • Zhongshan, Guangdong, China
    Zhongshan People's Hospital
Jul 23, 2022

Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Plasmacytoid; Lymphoma Trial in Shenzhen, Chengdu (BCMA-CD19 cCAR T

Recruiting
  • Multiple Myeloma in Relapse
  • +2 more
  • BCMA-CD19 cCAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
May 17, 2021

Hematologic Malignancy, Acute Myeloid Leukemia, MDS Trial in Chengdu, Shenzhen (CLL1-CD33 cCAR T cells)

Recruiting
  • Hematologic Malignancy
  • +4 more
  • CLL1-CD33 cCAR T cells
  • Chengdu, China
  • +1 more
May 17, 2021

Multiple Myeloma Trial in Chengdu, Shenzhen (BCMA-CS1 cCAR T cells)

Unknown status
  • Multiple Myeloma
  • BCMA-CS1 cCAR T cells
  • Chengdu, China
  • +1 more
Nov 8, 2019

B Cell Lymphoma, B Cell Leukemia Trial in Chengdu, Shanghai (CD20-CD19 cCAR T cells)

Unknown status
  • B Cell Lymphoma
  • B Cell Leukemia
  • CD20-CD19 cCAR T cells
  • Chengdu, China
  • +1 more
Nov 8, 2019

Hematologic Malignancy, Acute Myeloid Leukemia, MDS Trial in Chengdu, Shenzhen (CD123-CD33 cCAR T cells)

Unknown status
  • Hematologic Malignancy
  • +4 more
  • CD123-CD33 cCAR T cells
  • Chengdu, China
  • +1 more
Nov 8, 2019

Systemic Lupus Erythematosus Trial in Shanghai (Relma-cel)

Recruiting
  • Systemic Lupus Erythematosus
  • Relma-cel
  • Shanghai, China
    Relma-cel Medical
Mar 12, 2023

Opioid-Use Disorder (OUD) Trial in New Haven (Team Intervention)

Active, not recruiting
  • Opioid-Use Disorder (OUD)
  • Team Intervention
  • New Haven, Connecticut
  • +1 more
Nov 9, 2022

Solid Tumor Trial in Taichung (HLA-G-CAR.BiTE allogeneic ?d T cells)

Not yet recruiting
  • Solid Tumor
  • HLA-G-CAR.BiTE allogeneic γδ T cells
  • Taichung, Non-US, Taiwan
    China Medical University Hospital
Nov 27, 2023

B Cell Non-Hodgkin's Lymphoma Trial in Duarte (CD19/CD20-directed CAR-T cells)

Recruiting
  • B Cell Non-Hodgkin's Lymphoma
  • CD19/CD20-directed CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Aug 10, 2022

Dysphagia Trial in Ankara (Exercise Training)

Recruiting
  • Dysphagia
  • Exercise Training
  • Ankara, Turkey
    Hacettepe University
Feb 4, 2022